Your browser doesn't support javascript.
loading
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.
Morton, Colin; Baharlou, Samira; Basset-Seguin, Nicole; Calzavara-Pinton, Piergiacomo; Dirschka, Thomas; Gilaberte, Yolanda; Haedersdal, Merete; Hofbauer, Günther; Sapra, Sheetal; Waalboer-Spuij, Rick; Yip, Leona; Szeimies, Rolf-Markus.
Afiliación
  • Morton C; Department of Dermatology, NHS Forth Valley, Stirling, United Kingdom. colin.morton@nhs.scot.
  • Baharlou S; Department of Dermatology, Skin Immunology & Immune Tolerance (SKIN) Research Group, Vrije Universiteit Brussel, Brussels, Belgium; Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Basset-Seguin N; Université de Paris, Paris, France; Hôpital Saint-Louis, Paris, France.
  • Calzavara-Pinton P; Dermatology Department, University of Brescia, Brescia, Italy.
  • Dirschka T; CentroDerm Clinic, Wuppertal, Germany.
  • Gilaberte Y; Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain.
  • Haedersdal M; Department of Dermatology, Bispebjerg and Frederiksberg Hospitals, Copenhagen University Hospital, Copenhagen.
  • Hofbauer G; University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Sapra S; Oakville Trafalgar Memorial Hospital, Oakville, Canada; Institution of Cosmetic and Laser Surgery, Oakville, Canada.
  • Waalboer-Spuij R; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Yip L; Skin Partners, Brisbane, Australia.
  • Szeimies RM; Department of Dermatology & Allergology, Klinikum Vest GmbH Academic Teaching Hospital, Recklinghausen, Germany.
Acta Derm Venereol ; 103: adv6229, 2023 Jun 08.
Article en En | MEDLINE | ID: mdl-37289027
ABSTRACT
Actinic keratoses are pre-malignant skin lesions that require personalized care, a lack of which may result in poor treatment adherence and suboptimal outcomes. Current guidance on personalizing care is limited, notably in terms of tailoring treatment to individual patient priorities and goals and supporting shared decision-making between healthcare professionals and patients. The aim of the Personalizing Actinic Keratosis Treatment panel, comprised of 12 dermatologists, was to identify current unmet needs in care and, using a modified Delphi approach, develop recommendations to support personalized, long-term management of actinic keratoses lesions. Panellists generated recommendations by voting on consensus statements. Voting was blinded and consensus was defined as ≥ 75% voting 'agree' or 'strongly agree'. Statements that reached consensus were used to develop a clinical tool, of which, the goal was to improve understanding of disease chronicity, and the need for long-term, repeated treatment cycles. The tool highlights key decision stages across the patient journey and captures the panellist's ratings of treatment options for attributes prioritized by patients. The expert recommendations and the clinical tool can be used to facilitate patient-centric management of actinic keratoses in daily practice, encompassing patient priorities and goals to set realistic treatment expectations and improve care outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Queratosis Actínica / Medicina de Precisión Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Acta Derm Venereol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Queratosis Actínica / Medicina de Precisión Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Acta Derm Venereol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido